NCT03719885View on ClinicalTrials.gov

TrueTear in Sjogren's Disease Patients

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

April 25, 2019

Study Completion Date

December 31, 2019

Conditions
Dry Eye SyndromesSjogren's Syndrome
Interventions
DEVICE

TrueTear Intranasal Tear Neurostimulator

This study will evaluate the immediate tear production resulting from use of intranasal tear neurostimulation in patients with Sjogren's disease

Trial Locations (1)

19104

Scheie Eye Institute, University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT03719885 - TrueTear in Sjogren's Disease Patients | Biotech Hunter | Biotech Hunter